Research and development contract from broad agency announcement W81XWH18SBAA1, brainscope proposal BA180294 titled "multimodal brain function biomarker of mild TBI (mtbi) for rapid objective…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH18C0157
- Awardee
-
Brainscope Company, Inc. UEI Y1KLZUJ1E195
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $3,000,000
Award facts
- Opportunity
-
- W81XWH18SBAA1 Solicitation number
- Autonomous Delivery of Trauma Care in the Field Award Notice · Posted Sep 29, 2017
- Contract value 67% obligated
-
- $3,000,000.00 Current, with exercised options
- $4,500,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Bethesda, MD 20814, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,500,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,500,000 |
About this award
The Department of the Army Medical Command awarded a fixed-price level-of-effort research and development contract to Brainscope Co Inc., a for-profit manufacturer of goods. The $4,500,000.00 contract, awarded on August 31, 2018, is for the development of a multimodal brain function biomarker for the rapid, objective assessment of mildly head-injured individuals. The contract was solicited through Broad Agency Announcement W81XWH18SBAA1 and has a performance period ending on March 30, 2022. The contract does not have a set-aside designation. Brainscope Co Inc.'s primary customers are the Department of Defense (DOD) - Army and Navy, with the top buyer being jeanette.m.wolfe.civ@mail.mil from the DOD - Army.
Description
Research and development contract from broad agency announcement W81XWH18SBAA1, brainscope proposal BA180294 titled "multimodal brain function biomarker of mild TBI (mtbi) for rapid objective assessment of mildly head-injured individuals"
Quick answers
Who was awarded contract W81XWH18C0157?
W81XWH18C0157 was awarded to Brainscope Company, Inc. by Medical Command (Department of the Army) on August 31, 2018.
How much is contract W81XWH18C0157 worth?
The government has obligated $3,000,000 on W81XWH18C0157. Its potential value, with all options, is $4,500,000.
Was contract W81XWH18C0157 competed?
The extent of competition for W81XWH18C0157 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award